RELATIONSHIPS BETWEEN LEWY BODIES AND PALE BODIES IN PARKINSONS-DISEASE

被引:87
作者
DALE, GE
PROBST, A
LUTHERT, P
MARTIN, J
ANDERTON, BH
LEIGH, PN
机构
[1] INST PSYCHIAT, DEPT NEUROL, LONDON SE5 8AF, ENGLAND
[2] UNIV BASEL, DEPT PATHOL, DIV NEUROPATHOL, CH-4003 BASEL, SWITZERLAND
[3] ROYAL LONDON HOSP, DEPT PATHOL, LONDON E1 1BB, ENGLAND
[4] INST PSYCHIAT, DEPT NEUROSCI, LONDON SE5 8AF, ENGLAND
基金
英国惠康基金;
关键词
LEWY BODIES; PALE BODIES; SUBSTANTIA-NIGRA; PARKINSONS DISEASE-UBIQUITIN;
D O I
10.1007/BF00310030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The prevalence of pale bodies and Lewy bodies was studied in the substantia nigra of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lewy body disease (DLBD), and in a group of neurologically normal controls. Anti-ubiquitin antibodies labelled pale bodies and Lewy bodies in typical PD and DLBD, and there was a strong positive correlation between numbers of ubiquitin-immunoreactive pale bodies and Lewy bodies. BF10, a monoclonal antibody against a phosphate-dependent epitope of neurofilament 155-kDa polypeptide subunit, immunolabelled 57% of Lewy bodies and 15% of pale bodies in typical PD. Some pale bodies and Lewy bodies were seen in the substantia nigra of 2 of 5 neurologically normal, aged controls, probably representing "incidental PD". We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the substantia nigra in clinical varieties of PD, and that these inclusions share antigenic determinants. If pale bodies and Lewy bodies reflect separate aspects of the cellular pathology in PD, their formation probably occurs in parallel. Alternatively, these observations may suggest that pale bodies represent a stage in the formation of Lewy bodies.
引用
收藏
页码:525 / 529
页数:5
相关论文
共 36 条
  • [1] MONOCLONAL-ANTIBODIES SHOW THAT NEUROFIBRILLARY TANGLES AND NEUROFILAMENTS SHARE ANTIGENIC DETERMINANTS
    ANDERTON, BH
    BREINBURG, D
    DOWNES, MJ
    GREEN, PJ
    TOMLINSON, BE
    ULRICH, J
    WOOD, JN
    KAHN, J
    [J]. NATURE, 1982, 298 (5869) : 84 - 86
  • [2] AN ANTIGENIC PROFILE OF LEWY BODIES - IMMUNOCYTOCHEMICAL INDICATION FOR PROTEIN-PHOSPHORYLATION AND UBIQUITINATION
    BANCHER, C
    LASSMANN, H
    BUDKA, H
    JELLINGER, K
    GRUNDKEIQBAL, I
    IQBAL, K
    WICHE, G
    SEITELBERGER, F
    WISNIEWSKI, HM
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (01) : 81 - 93
  • [3] UBIQUITIN PROTEIN CONJUGATES IN ALZHEIMERS LESIONS
    COLE, GM
    TIMIRAS, PS
    [J]. NEUROSCIENCE LETTERS, 1987, 79 (1-2) : 207 - 212
  • [4] DIFFUSE LEWY BODY DISEASE - LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY OF SENILE PLAQUES
    DICKSON, DW
    CRYSTAL, H
    MATTIACE, LA
    KRESS, Y
    SCHWAGERL, A
    KSIEZAKREDING, H
    DAVIES, P
    YEN, SHC
    [J]. ACTA NEUROPATHOLOGICA, 1989, 78 (06) : 572 - 584
  • [5] REACTION OF LEWY BODIES WITH ANTIBODIES TO PHOSPHORYLATED AND NONPHOSPHORYLATED NEUROFILAMENTS
    FORNO, LS
    STERNBERGER, LA
    STERNBERGER, NH
    STREFLING, AM
    SWANSON, K
    ENG, LF
    [J]. NEUROSCIENCE LETTERS, 1986, 64 (03) : 253 - 258
  • [6] LEWY BODIES CONTAIN EPITOPES BOTH SHARED AND DISTINCT FROM ALZHEIMER NEUROFIBRILLARY TANGLES
    GALLOWAY, PG
    GRUNDKEIQBAL, I
    IQBAL, K
    PERRY, G
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (06) : 654 - 663
  • [7] THE PRESENCE OF TAU DISTINGUISHES LEWY BODIES OF DIFFUSE LEWY BODY DISEASE FROM THOSE OF IDIOPATHIC PARKINSON DISEASE
    GALLOWAY, PG
    BERGERON, C
    PERRY, G
    [J]. NEUROSCIENCE LETTERS, 1989, 100 (1-3) : 6 - 10
  • [8] THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE
    GIBB, WRG
    LEES, AJ
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1989, 15 (01) : 27 - 44
  • [9] THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE
    GIBB, WRG
    LEES, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) : 745 - 752
  • [10] CORTICOBASAL DEGENERATION
    GIBB, WRG
    LUTHERT, PJ
    MARSDEN, CD
    [J]. BRAIN, 1989, 112 : 1171 - 1192